Research graph
References from Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder. Local targets link to admitted publications; unresolved targets remain external evidence.
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis
10.1016/s2215-0366(18)30269-4 · 2018 · External reference
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response
10.1176/appi.ajp.2007.05091676 · 2008 · External reference
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
10.1371/journal.pmed.1000097 · 2009 · External reference
Unresolved reference
2001 · External reference
Unresolved reference
2014 · External reference
Genetic variations in attention deficit hyperactivity disorder subtypes and treatment resistant cases
10.4306/pi.2016.13.4.427 · 2016 · External reference
Combining independent p values: Extensions of the Stouffer and binomial methods
10.1037/1082-989x.5.4.496 · 2000 · External reference
Attention deficit hyperactivity disorder: Genetic association study in a cohort of Spanish children
10.1186/s12993-015-0084-6 · 2015 · External reference
Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder
10.1001/archpsyc.64.2.218 · 2007 · External reference
Adrenergic α2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type
10.1007/s00702-007-0835-0 · 2008 · External reference
Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder
10.1016/j.biopsych.2008.12.003 · 2009 · External reference
Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
10.1007/s00406-010-0172-4 · 2011 · External reference
Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder
10.1016/j.jaac.2011.08.002 · 2011 · External reference
Norepinephrine transporter −3081 (A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment
10.1177/0269881111405356 · 2012 · External reference
Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in Korean children with attention-deficit/hyperactivity disorder: Is there an interaction?
10.1089/cap.2011.0076 · 2012 · External reference
Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder
10.1097/jcp.0b013e31828f9fc3 · 2013 · External reference
No significant association between the alpha-2A-adrenergic receptor gene and treatment response in combined or inattentive subtypes of attention-deficit hyperactivity disorder
10.1055/s-0033-1343485 · 2013 · External reference
Predicting methylphenidate response in ADHD using machine learning approaches
10.1093/ijnp/pyv052 · 2015 · External reference
A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: Results from a naturalistic study
10.1007/s00702-016-1540-7 · 2016 · External reference
The alpha-2A adrenergic receptor gene-1291C/G single nucleotide polymorphism is associated with the efficacy of methylphenidate in treating Taiwanese children and adolescents with attention-deficit hyperactivity disorder
10.30773/pi.2017.07.24 · 2018 · External reference
Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD
10.1038/mp.2017.234 · 2018 · External reference
